Indonesia Including 10 Countries With The Highest Number Of Ovarium Cancer Cases

Illustration (image: Pexels/Anna Tarazevich)

JAKARTA - Ovarium cancer is the uncontrolled growth of cancer cells in the ovarian or egg protection. Global Cancer Observatory (GLOBOCAN) 2022 data shows that ovarian cancer ranks third as the most cancer in women in Indonesia.

Indonesia is also included in 10 countries with the highest number of ovarian cancer cases in the world. In Indonesia, every year there will be around 15 thousand new cases of ovarian cancer, with the death of more than 9 thousand.

"Indonesia is included in 10 countries with the highest number of ovarian cancer cases in the world, with 15,130 new cases every year," said Obstetrician and Gynecology Specialist, Oncology Consultant, dr. Muhammad Yusuf, Sp.OG (K) Onk, during a press conference in Gatot Subroto, Jakarta, on Thursday, July 24, 2025.

This makes ovarian cancer one of the diseases to watch out for. However, the number of cases shows how low public awareness is about ovarian cancer.

"This figure reflects the low level of public awareness regarding ovarian cancer, as well as limited education around risk factors," he added.

Therefore, it is very important to increase public awareness regarding the dangers of ovarian cancer. Not only that, sustainable education, especially for women, is important to do to reduce case growth and improve the quality of handling.

Starting from education, living a healthy lifestyle has an important role to play in reducing the risk of ovarian cancer. Then the importance of early detection of reproductive health, especially for those with a history of cancer sufferers, maintaining ideal weight, and avoiding hormone therapy.

With that, the biofarmasi company AstraZeneca is committed to continuing to help educate the public about ovarian cancer. Not only introducing the disease, but also education about the treatment and development of a more responsive health system for ovarian cancer in Indonesia.

Our commitment also includes increasing awareness and expanding access to treatment for ovarian cancer patients. Education regarding the importance of proper treatment access to treatment options is the first step in building a more responsive health system for the needs of ovarian cancer patients in Indonesia," concluded AstraZeneca Indonesia President Director Esra Erkomay.